TENSIVE s.r.l. is a biomedical company based in Milan, Italy, founded in 2012. It specializes in the development of innovative prostheses for natural breast reconstruction and augmentation. The company's products utilize biodegradable synthetic biomaterials and feature an internal micro-architecture that mimics blood vessel structures. These vascularized prostheses aim to enhance the quality of life for patients undergoing treatment for breast cancer, offering a solution that reduces the need for recurrent and costly surgical interventions. Through its focus on advanced biomaterials and design, TENSIVE seeks to provide effective and sustainable options for breast reconstruction.
BetaGlue Technologies
Seed Round in 2022
BetaGlue Technologies SpA specializes in the development and manufacture of medical devices designed for loco-regional radiation therapy targeting unresectable solid tumors. The company's innovative product utilizes a proprietary beta-emitting bio-compatible matrix, facilitating the controlled administration of radionuclides directly into tumor masses. This technology not only aims to enhance treatment efficacy but also plays a crucial role in preventing complications that may arise from procedures such as lung and liver biopsies and other localized treatments. Headquartered in Milan, Italy, BetaGlue Technologies is focused on advancing therapeutic options in the field of oncology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.